Creative Medical Technology Holdings, Inc. Common Stock
2.27
USD
Patrocinado
-0.18
-7.35%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.31
+0.04
+1.98%
Relatórios de Lucros CELZ
Rácio de surpresa positiva
CELZ separação 7 de 16 últimas estimativas.
44%
Próximo Relatório
Data do Próximo Relatório
12 de mar. de 2026
Estimate forQ4 25(Revenue/ EPS)
--
/
-$0.37
Mudanças implicadas deQ3 25(Revenue/ EPS)
--
/
-22.92%
Mudanças implicadas deQ4 24(Revenue/ EPS)
-100.00%
/
-66.96%
Creative Medical Technology Holdings, Inc. Common Stock earnings per share and revenue
On 07 de nov. de 2025, CELZ reported earnings of -0.48 USD per share (EPS) for Q3 25, beating the estimate of -0.48 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.37 USD, with revenue projected to reach -- USD, implying an diminuir of -22.92% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Creative Medical Technology Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Creative Medical Technology Holdings, Inc. Common Stock reported EPS of -$0.48, beating estimates by 1.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Creative Medical Technology Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 8.61%, changed from $3.02 before the earnings release to $3.28 the day after.
When is Creative Medical Technology Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for 12 de mar. de 2026.
What are the forecasts for Creative Medical Technology Holdings, Inc. Common Stock's next earnings report?
Based on 3
analistas, Creative Medical Technology Holdings, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of -- for Q4 2025.